Suzanne Crowe Biography and Net Worth

Director of AVITA Medical

Professor Suzanne Crowe AO, has served as a Non-Executive Director of AVITA Medical since January 2016. Australian-based, she is a physician-scientist and ASX/Nasdaq-listed company director with expertise in supporting companies with their medical and scientific strategies. A Fellow of the Australian Institute of Company Directors, she is currently a Non-Executive Director of St Vincent’s Health Australia Ltd, the country’s largest not-for-profit health and aged care provider, and Non-Executive Director of Sonic Healthcare Ltd, a large global medical diagnostic company. She was appointed Emeritus Professor, Monash University, Melbourne in 2020. After 35 years at both, she has recently retired from the Burnet Institute, having served as Associate Director Clinical Research, and the university-affiliated Alfred Hospital Melbourne, where she held the appointment of Senior Specialist Physician in Infectious Diseases. She was appointed as Officer of the Order of Australia in June 2020 in recognition of her distinguished services to health, clinical governance, biomedical research and education.

What is Suzanne Crowe's net worth?: The estimated net worth of Suzanne Crowe is at least $322,241.76 as of December 9th, 2024. Dr. Crowe owns 36,912 shares of AVITA Medical stock worth more than $322,242 as of March 30th. This net worth approximation does not reflect any other assets that Dr. Crowe may own. Learn More about Suzanne Crowe's net worth.
How do I contact Suzanne Crowe?: The corporate mailing address for Dr. Crowe and other AVITA Medical executives is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. AVITA Medical can also be reached via phone at (833) 462-8482 and via email at investor@avitamedical.com. Learn More on Suzanne Crowe's contact information.
Has Suzanne Crowe been buying or selling shares of AVITA Medical?: Suzanne Crowe has not been actively trading shares of AVITA Medical during the past quarter. Most recently, on Monday, December 9th, Suzanne Crowe bought 486 shares of AVITA Medical stock. The stock was acquired at an average cost of $13.15 per share, with a total value of $6,390.90. Following the completion of the transaction, the director now directly owns 36,912 shares of the company's stock, valued at $485,392.80. Learn More on Suzanne Crowe's trading history.
Who are AVITA Medical's active insiders?: AVITA Medical's insider roster includes Suzanne Crowe (Director), and Michael Perry (CEO). Learn More on AVITA Medical's active insiders.
Are insiders buying or selling shares of AVITA Medical?: In the last year, AVITA Medical insiders bought shares 5 times. They purchased a total of 13,461 shares worth more than $138,589.40. The most recent insider tranaction occured on February, 20th when Director Robert Mcnamara bought 10,000 shares worth more than $100,900.00. Insiders at AVITA Medical own 1.8% of the company. Learn More about insider trades at AVITA Medical.
Information on this page was last updated on 2/20/2025.

Suzanne Crowe Insider Trading History at AVITA Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/9/2024	Buy	486	$13.15	$6,390.90	36,912
9/20/2021	Buy	1,066	$17.08	$18,207.28

Suzanne Crowe Buying and Selling Activity at AVITA Medical

AVITA Medical Company Overview

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Today's Range

Now: $8.73

$8.66

$9.19

50 Day Range

MA: $9.12

$8.27

$10.57

2 Week Range

Now: $8.73

$7.51

$15.98

Volume

99,567 shs

Average Volume

187,212 shs

Market Capitalization

$228.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57